Novo Nordisk A/S
NONOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $14 | $13 | $11 |
| Short-Term Investments | $11 | $16 | $11 | $7 |
| Receivables | $87 | $75 | $58 | $47 |
| Inventory | $41 | $32 | $24 | $20 |
| Other Curr. Assets | $6 | $2 | $3 | $2 |
| Total Curr. Assets | $161 | $140 | $108 | $86 |
| Property Plant & Equip (Net) | $162 | $91 | $67 | $55 |
| Goodwill | $20 | $4 | $5 | $4 |
| Intangibles | $91 | $56 | $46 | $39 |
| Long-Term Investments | $3 | $2 | $1 | $1 |
| Tax Assets | $25 | $20 | $13 | $9 |
| Other NC Assets | $4 | $1 | $0 | $0 |
| Total NC Assets | $305 | $175 | $133 | $109 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $466 | $314 | $241 | $195 |
| Liabilities | – | – | – | – |
| Payables | $29 | $26 | $16 | $9 |
| Short-Term Debt | $13 | $6 | $1 | $14 |
| Tax Payable | $10 | $7 | $7 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $55 |
| Other Curr. Liab. | $166 | $138 | $104 | -$37 |
| Total Curr. Liab. | $218 | $170 | $121 | $100 |
| LT Debt | $90 | $21 | $24 | $13 |
| Deferred Rev, NC | $0 | $0 | $0 | $6 |
| Deferred Tax Liab, NC | $5 | $10 | $7 | $5 |
| Other NC Liab. | $10 | $8 | $5 | $0 |
| Total NC Liab. | $105 | $38 | $37 | $24 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $6 | $5 | $4 |
| Total Liabilities | $322 | $208 | $158 | $124 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $144 | $105 | $81 | $72 |
| AOCI | -$1 | $1 | $2 | -$2 |
| Other Equity | -$0 | -$0 | -$0 | -$0 |
| Total Equity | $143 | $107 | $83 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $466 | $314 | $241 | $195 |
| Net Debt | $87 | $13 | $13 | $16 |